DK0891186T3 - Nasal administration af middel til behandling af forsinket opkastning - Google Patents

Nasal administration af middel til behandling af forsinket opkastning

Info

Publication number
DK0891186T3
DK0891186T3 DK97915060.4T DK97915060T DK0891186T3 DK 0891186 T3 DK0891186 T3 DK 0891186T3 DK 97915060 T DK97915060 T DK 97915060T DK 0891186 T3 DK0891186 T3 DK 0891186T3
Authority
DK
Denmark
Prior art keywords
agent
treatment
nasal administration
delayed vomiting
delayed
Prior art date
Application number
DK97915060.4T
Other languages
English (en)
Inventor
Mary Psilogenis
Original Assignee
Evoke Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evoke Pharma Inc filed Critical Evoke Pharma Inc
Application granted granted Critical
Publication of DK0891186T3 publication Critical patent/DK0891186T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK97915060.4T 1996-03-14 1997-03-13 Nasal administration af middel til behandling af forsinket opkastning DK0891186T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/616,121 US5760086A (en) 1996-03-14 1996-03-14 Nasal administration of agents for treatment of delayed onset emesis
PCT/US1997/003974 WO1997033573A1 (en) 1996-03-14 1997-03-13 Nasal administration of agents for treatment of delayed onset emesis

Publications (1)

Publication Number Publication Date
DK0891186T3 true DK0891186T3 (da) 2011-03-14

Family

ID=24468120

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97915060.4T DK0891186T3 (da) 1996-03-14 1997-03-13 Nasal administration af middel til behandling af forsinket opkastning

Country Status (24)

Country Link
US (1) US5760086A (da)
EP (1) EP0891186B1 (da)
JP (1) JP2000507234A (da)
KR (1) KR100420673B1 (da)
CN (1) CN1217657A (da)
AT (1) ATE489137T1 (da)
AU (1) AU707467B2 (da)
BG (1) BG102780A (da)
CA (1) CA2248968C (da)
CZ (1) CZ289797B6 (da)
DE (1) DE69740060D1 (da)
DK (1) DK0891186T3 (da)
EE (1) EE03665B1 (da)
ES (1) ES2357520T3 (da)
IL (1) IL126199A (da)
NO (1) NO984245L (da)
NZ (1) NZ331991A (da)
PL (1) PL328940A1 (da)
PT (1) PT891186E (da)
RU (1) RU2181588C2 (da)
SK (1) SK282695B6 (da)
UA (1) UA57733C2 (da)
WO (1) WO1997033573A1 (da)
YU (1) YU40398A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
CN102209470B (zh) * 2008-11-11 2013-03-13 荷兰联合利华有限公司 茶组合物
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
ES2536885T3 (es) 2008-12-22 2015-05-29 Evoke Pharma, Inc. Formulaciones nasales de metoclopramida
US20110165143A1 (en) * 2010-01-06 2011-07-07 The Regents Of The University Of Colorado, A Body Corporate Modulation of caspases and therapeutical applications
PL2747561T3 (pl) 2011-08-25 2018-11-30 Evoke Pharma, Inc. Leczenie objawów związanych z gastroparezą u osobników płci żeńskiej
FR2980976B1 (fr) 2011-10-10 2015-10-16 Mohamed Skiba Composition pharmaceutique pour l'administration par voie nasale de la metopimazine
CN104606136A (zh) * 2015-01-06 2015-05-13 中国人民解放军军事医学科学院毒物药物研究所 甲氧氯普胺鼻腔喷雾剂、其制备方法及用途
WO2018112061A1 (en) 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624965A (en) * 1984-11-15 1986-11-25 Nastech Pharmaceutical Co., Inc. Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same

Also Published As

Publication number Publication date
JP2000507234A (ja) 2000-06-13
IL126199A (en) 2004-06-01
KR100420673B1 (ko) 2004-07-23
NZ331991A (en) 2000-04-28
AU2210297A (en) 1997-10-01
NO984245L (no) 1998-11-11
CN1217657A (zh) 1999-05-26
RU2181588C2 (ru) 2002-04-27
CZ292298A3 (cs) 1999-03-17
CA2248968A1 (en) 1997-09-18
SK125998A3 (en) 1999-03-12
BG102780A (en) 2000-01-31
AU707467B2 (en) 1999-07-08
EP0891186A4 (en) 2004-03-31
PL328940A1 (en) 1999-03-01
EP0891186A1 (en) 1999-01-20
ES2357520T3 (es) 2011-04-27
PT891186E (pt) 2011-02-25
KR19990087763A (ko) 1999-12-27
UA57733C2 (uk) 2003-07-15
ATE489137T1 (de) 2010-12-15
US5760086A (en) 1998-06-02
DE69740060D1 (de) 2011-01-05
EE03665B1 (et) 2002-04-15
EP0891186B1 (en) 2010-11-24
NO984245D0 (no) 1998-09-14
CA2248968C (en) 2005-08-02
YU40398A (sh) 2001-07-10
CZ289797B6 (cs) 2002-04-17
SK282695B6 (sk) 2002-11-06
WO1997033573A1 (en) 1997-09-18
EE9800295A (et) 1999-02-15
IL126199A0 (en) 1999-05-09

Similar Documents

Publication Publication Date Title
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DK0946507T3 (da) Substituerede pyrrolylforbindelser til behandling af inflammation
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK0891186T3 (da) Nasal administration af middel til behandling af forsinket opkastning
DK0888323T3 (da) Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
DK1032414T3 (da) Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet
DK1001761T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser
DK0684816T3 (da) 5-HT2-receptorantagonister til behandling af venöse tilstande
AU4726797A (en) Prophylactic/remedial agent
DK0910379T3 (da) Plaster til transdermal påføring af pergolid
ID26806A (id) SENYAWA BARU YANG BERASAL DARI a-D-SILOSA, METODA PEMBUATAN DAN PENGGUNAAN TERAPINYA
MX9300601A (es) Compuestos de arilalcoxifenoxi-imidazolina.
DK0796256T3 (da) Fremgangsmåde til fremstilling af ranitidin
ES2187809T3 (es) Procedimiento para preparar compuestos de bernzopirano.
DK1017377T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande
DK0948338T3 (da) Anvendelse af et på æg baseret præparat som antidepressivt middel